Cargando…
Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is a B-cell malignancy characterized by a wide range of tumor-induced alterations, which affect both the innate and adaptive arms of the immune response, and accumulate during disease progression. In recent years, the development of targeted therapies, such as the...
Autores principales: | Griggio, Valentina, Perutelli, Francesca, Salvetti, Chiara, Boccellato, Elia, Boccadoro, Mario, Vitale, Candida, Coscia, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708380/ https://www.ncbi.nlm.nih.gov/pubmed/33312177 http://dx.doi.org/10.3389/fimmu.2020.594556 |
Ejemplares similares
-
Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia
por: Vitale, Candida, et al.
Publicado: (2021) -
Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs
por: Vitale, Candida, et al.
Publicado: (2020) -
CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?
por: Vitale, Candida, et al.
Publicado: (2023) -
Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges
por: Perutelli, Francesca, et al.
Publicado: (2022) -
Targeting HIF-1α Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL
por: Vitale, Candida, et al.
Publicado: (2021)